Literature DB >> 23582590

Oral health risk factors for bisphosphonate-associated jaw osteonecrosis.

Claudine Tsao1, Ivan Darby, Peter R Ebeling, Katrina Walsh, Neil O'Brien-Simpson, Eric Reynolds, Gelsomina Borromeo.   

Abstract

PURPOSE: To investigate the role of oral health, including periodontitis, as a risk factor for bisphosphonate-associated jaw osteonecrosis (ONJ).
MATERIALS AND METHODS: This cross-sectional study compared cases with an ONJ history to controls. All had a history of bisphosphonate treatment for malignancy. Participants underwent oral examination, gingival crevicular fluid (GCF) sampling, and phlebotomy. Serum was analyzed for biochemical parameters, bone markers, and immunoglobulin G titers against 4 periodontitis-associated bacteria. Cytokine levels were determined in GCF using a multiplex assay.
RESULTS: Caries development was comparable between groups. Periodontitis was significantly associated with ONJ using the US National Center for Health Statistics periodontitis definition (P = .002), at least 1 site with a probing depth of at least 4 mm (P = .003), and the percentage of sites per participant with a probing depth of 4 to 5 mm (P = .044). Immunoglobulin G titer against Porphyromonas gingivalis and GCF interleukin-1β level were also significantly associated with ONJ (P = .018 and P = .044, respectively).
CONCLUSION: In participants with a history of bisphosphonate treatment for malignancy, periodontitis was associated with ONJ when measured using clinical parameters, serum immunoglobulin G titers against P gingivalis, and GCF interleukin-1β levels, suggesting that periodontitis and associated bacteria are potentially important in ONJ pathophysiology.
Copyright © 2013 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23582590     DOI: 10.1016/j.joms.2013.02.016

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  32 in total

1.  [Oral implant treatment for elderly patients].

Authors:  Quan Yuan
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

2.  Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.

Authors:  Akihiko Matsumoto; Masanori Sasaki; Rainer Schmelzeisen; Yukiko Oyama; Yoshihide Mori; Pit Jacob Voss
Journal:  Clin Oral Investig       Date:  2016-02-29       Impact factor: 3.573

3.  Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?

Authors:  Nobuhiro Ueda; Chie Nakashima; Kumiko Aoki; Hiroko Shimotsuji; Kazuhiko Nakaue; Hajime Yoshioka; Satoshi Kurokawa; Yuichiro Imai; Tadaaki Kirita
Journal:  Clin Oral Investig       Date:  2020-10-14       Impact factor: 3.573

4.  The Prevention of Medication-related Osteonecrosis of the Jaw.

Authors:  Philipp Poxleitner; Monika Engelhardt; Rainer Schmelzeisen; Pit Voss
Journal:  Dtsch Arztebl Int       Date:  2017-02-03       Impact factor: 5.594

5.  Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.

Authors:  Adepitan A Owosho; Ariel Blanchard; Lauren Levi; Arvin Kadempour; Haley Rosenberg; SaeHee K Yom; Azeez Farooki; Monica Fornier; Joseph M Huryn; Cherry L Estilo
Journal:  J Craniomaxillofac Surg       Date:  2015-12-20       Impact factor: 2.078

6.  Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.

Authors:  K M Kim; W Park; S Y Oh; H-J Kim; W Nam; S-K Lim; Y Rhee; I H Cha
Journal:  Osteoporos Int       Date:  2014-02-20       Impact factor: 4.507

7.  Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report.

Authors:  Do-Sup Kim; Jung-Ho Kim; Joo-Young Ohe; Jung-Woo Lee; Byung-Jun Choi; Baek-Soo Lee; Yong-Dae Kwon
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-12-17

Review 8.  Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis.

Authors:  H Devlin; J Greenwall-Cohen; J Benton; T L Goodwin; A Littlewood; K Horner
Journal:  Br Dent J       Date:  2017-11-17       Impact factor: 1.626

9.  Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.

Authors:  A Shudo; H Kishimoto; K Takaoka; K Noguchi
Journal:  Osteoporos Int       Date:  2018-07-02       Impact factor: 4.507

10.  The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.

Authors:  Erofili Papadopoulou; Ourania Nicolatou-Galitis; Ioannis Papassotiriou; Helena Linardou; Aikaterini Karagianni; Konstantinos Tsixlakis; Anthi Tarampikou; Kelly Michalakakou; Emmanouil Vardas; Dimitrios Bafaloukos
Journal:  Support Care Cancer       Date:  2019-04-17       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.